Standard TB treatment

DRUG4 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Damien Foundation, The Aurum Institute NPC, Open Source Pharma Foundation

Conditions

HIV InfectionsTuberculosisTuberculosis (TB)Tuberculosis, Pulmonary

Phase 3

Optimization of the TB Treatment Regimen Cascade

CompletedNCT02153528

Damien FoundationTuberculosis, Pulmonary

Start: 2014-11-30End: 2017-08-01Updated: 2020-02-13

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Not yet recruitingNCT07136987

Open Source Pharma FoundationTuberculosis

Start: 2026-01-31End: 2031-07-31Target: 1104Updated: 2025-08-22

Unknown Phase

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

CompletedNCT00091936

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

Start: 2009-08-31Target: 592Updated: 2010-03-29

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

RecruitingNCT06909799

The Aurum Institute NPCTuberculosis (TB)

Start: 2025-04-28End: 2027-12-31Target: 242Updated: 2025-04-30

Related Papers

Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.

2019-12-0522 citations